Dr. Dmitry Nemirovsky, M.D.
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Medical school
- Vanderbilt University School of Medicine (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,143
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: Vanderbilt University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
NJ license 25MA08223300 · NY license 224143
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hackensack University Medical Center Hackensack, NJ
- Englewood Hospital and Medical Center Englewood, NJ
- Hackensack Meridian Health PAscack Valley Medical Westwood, NJ
Medical groups
- Hackensack Meridian Health Medical Group - Specialty Care PC (1,922 clinicians)
- Medical Associates of Englewood PC (540 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,143
- Services billed
- 4,144
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 689 | 599 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 464 | 143 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 344 | 104 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 318 | 98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 288 | 195 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 264 | 42 |
| Programming of dual lead pacemaker system | 162 | 112 |
| Established patient office or other outpatient visit, 30-39 minutes | 153 | 109 |
| Established patient office or other outpatient visit, 20-29 minutes | 118 | 92 |
| Established patient office or other outpatient visit, 40-54 minutes | 106 | 83 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Englewood, NJ | 93 |
| Amiodarone Hcl Other prescribers in Englewood, NJ | 72 |
| Eliquis (apixaban) Other prescribers in Englewood, NJ | 72 |
| Xarelto (rivaroxaban) Other prescribers in Englewood, NJ | 21 |
| Flecainide Acetate Other prescribers in Englewood, NJ | 15 |
| Multaq (dronedarone hcl) Other prescribers in Englewood, NJ | 12 |
| Dofetilide | 11 |
| Metoprolol Tartrate Other prescribers in Englewood, NJ | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 42 payments worth $9,738 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $8,340 |
|---|---|
| Medtronic, Inc. | $472 |
| Abbott Laboratories | $321 |
| Boston Scientific Corporation | $243 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $149 |
| Cordis US Corp. | $98.09 |
| Kestra Medical Technology Services, Inc. | $28.99 |
| Cardiva Medical, Inc. | $18.44 |
| Compensation for services other than consulting (speaking, faculty) | $8,160 |
|---|---|
| Food and Beverage | $1,578 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) CAMZYOS · Cardiovascular | $4,080 |
| E.r. Squibb & Sons, L.l.c. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) CAMZYOS · Cardiovascular | $4,080 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $20,979 in research payments for these studies, mostly to the institutions running them.
- A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic C…
E.r. Squibb & Sons, L.l.c.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.